Chemotherapy
Treatment / Clinical trials

Clinical trials

A treatment option that allows patients to gain access to cancer treatments that are not FDA-approved.

Purpose of clinical trials

Clinical trials are experiments using human studies. Some patients enroll in clinical trials which allow them to gain access to cancer cancer A term used to describe diseases in which abnormal cells continually divide without normal regulation. Cancerous cells may invade surrounding tissues and may spread to other regions of the body via blood and the lymphatic system. treatments that are not FDA-approved. For MCC, there are active clinical trials using immune checkpoint inhibitors immune checkpoint inhibitors Immune checkpoint inhibitors (ICIs) are therapies that turns on the immune system by blocking an inhibitor (a 'checkpoint') that normally restrains the immune system. Such agents can sometimes cause the immune system to recognize and destroy a cancer. . Please visit our Immunotherapy page for more information on these agents. There is a need for more patients to enroll in clinical trials, as outlined by an MCC patient in the New York Times.

Who this works for

MCC patients with advanced stages that meet the clinical trial’s eligibility.

Who this doesn’t work for

Patients that do not meet the clinical trial’s eligibility, or who are unable to travel to the site at which the trial is being performed.

Side effects

Depending on the agent, there are many side effects ranging from fatigue to autoimmune responses.

Often used in conjunction with

Trials are very specific as to what can be used together with the agent being tested.

What to do next

Please explore the National Institutes of Health’s website to learn more about active MCC clinical trials, their eligibility requirements, and location sites.

FAQs

What kind of treatments are administered on Merkel cell carcinoma clinical trials?

Typically, MCC clinical trials administer immune checkpoint inhibitors but also include chemotherapy, certain types of radiation, and combinations of therapies. Please explore the National Institutes of Health’s website to learn more about active MCC clinical trials, their eligibility, and location sites.

What are the requirements for Merkel cell carcinoma clinical trials?

Every clinical trial have a different set of requirements, but can limit enrollment based on age, tumor size, extent of disease, past treatments and immune status.